The Magnum Ice Cream Company N.V. Ordinary Shares vs NeoGenomics Inc. Common Stock — how do they compare? The Magnum Ice Cream Company N.V. Ordinary Shares trades at $17.92 (market cap $10.72B), while NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B). The key difference: The Magnum Ice Cream Company N.V. Ordinary Shares is far larger — about 5× NeoGenomics Inc. Common Stock's market cap, and NeoGenomics Inc. Common Stock is more actively traded (2,228,400 versus 1,309,650). Which is the better fit depends on your goals — on Pluang, investors hold The Magnum Ice Cream Company N.V. Ordinary Shares for 0 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| MICC | NEO | |
|---|---|---|
Market Cap | $10.72B | $2.14B |
Volume | 1,309,650 | 2,228,400 |
Sector | Consumer Staples | Health |
52-Week High | $20.42 | $19.91 |
52-Week Low | $13.06 | $7.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.14B | $2.44B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
The Magnum Ice Cream Company N.V. manufactures and sells ice cream and frozen desserts through brands including Magnum, Ben & Jerry's, Wall's, and Cornetto, distributing across roughly 80 countries.
Read more on MICC →NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →